GLP-1 drugs currently available for weight loss are administered as once-weekly injections. Verdiva Bio also aims to bring to patients once-a-week dosing, but in a more convenient pill. That would ...

Cancer drugs are always popular biotech investments, but autoimmune disease also figures prominently in the startup ...

This week, Congress reached a bipartisan healthcare deal as part of a larger $1.2 trillion spending bill, combining funding ...

President Donald Trump unveiled the Great Healthcare Plan to lower drug costs and insurance premiums, but healthcare ...

Roughly 31,000 Kaiser Permanente nurses and other healthcare professionals are planning to launch an open-ended strike starting on Monday. Their main grievances are chronic understaffing, rising ...

During two House hearings, health insurance CEOs were questioned on rising healthcare costs, vertical integration and prior authorization.

Epic Systems and several healthcare providers have sued Health Gorilla and other companies, alleging they exploited ...

The Trump administration’s flagship budget package, dubbed the One Big Beautiful Bill Act, is advancing through Congress and is currently awaiting a vote in the Senate. The bill includes the biggest ...

It’s not often that a pharmaceutical executive discusses a competitor’s success. Alkermes Chief Operating Officer Blair Jackson not only talks about it openly, he cheers it. Alkermes’s scope in ...

The prosthetics field’s main problem isn’t just designing better devices — it’s the lack of data to guide which device is best for each patient, according to one executive in the space. Josh Caputo, ...

BioNTech’s oncology strategy centers on a bispecific antibody that the company envisions as the backbone of many potential drug combinations for many types of cancer. Bristol Myer Squibb is buying ...